Case Study – Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we managed cell isolation and counts among other routine and speciality tests for a large Relapse Refractory Multiple Myeloma study over 11,000 samples managed.
Tests including FCM, PBMC isolation and count, FISH
Case Study – Phase 2 Relapse Refractory Multiple Myeloma (RRMM)
![Cerba US Expansion Tour VF.00_04_27_19.Still010](https://cerbaresearch.com/app/uploads/2022/07/Cerba-US-Expansion-Tour-VF.00_04_27_19.Still010.jpg)
Reach out to our experts and discover how we can help you advance your clinical trial
Contact Us